Genetic Support for Longevity-Enhancing Drug Targets: Issues, Preliminary Data, and Future Directions
Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are naturally occurring genetic variants in such a target that affect longevity as well as the molecular function of that target (eg, the varian...
Uloženo v:
| Vydáno v: | The journals of gerontology. Series A, Biological sciences and medical sciences Ročník 74; číslo Suppl_1; s. S61 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
13.11.2019
|
| Témata: | |
| ISSN: | 1758-535X, 1758-535X |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are naturally occurring genetic variants in such a target that affect longevity as well as the molecular function of that target (eg, the variants influence the expression of the target, acting as "expression quantitative trait loci" or "eQTLs"), this could support a causal relationship between the pharmacologic modulation of the target and longevity and thereby validate the target at some level. We considered the gene targets of many pharmacologic interventions hypothesized to enhance human longevity and explored how many variants there are in those targets that affect gene function (eg, as expression quantitative trait loci). We also determined whether variants in genes associated with longevity-related phenotypes affect gene function or are in linkage disequilibrium with variants that do, and whether pharmacologic studies point to compounds exhibiting activity against those genes. Our results are somewhat ambiguous, suggesting that integrating genetic association study results with functional genomic and pharmacologic studies is necessary to shed light on genetically mediated targets for longevity-enhancing drugs. Such integration will require more sophisticated data sets, phenotypic definitions, and bioinformatics approaches to be useful. |
|---|---|
| AbstractList | Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are naturally occurring genetic variants in such a target that affect longevity as well as the molecular function of that target (eg, the variants influence the expression of the target, acting as "expression quantitative trait loci" or "eQTLs"), this could support a causal relationship between the pharmacologic modulation of the target and longevity and thereby validate the target at some level. We considered the gene targets of many pharmacologic interventions hypothesized to enhance human longevity and explored how many variants there are in those targets that affect gene function (eg, as expression quantitative trait loci). We also determined whether variants in genes associated with longevity-related phenotypes affect gene function or are in linkage disequilibrium with variants that do, and whether pharmacologic studies point to compounds exhibiting activity against those genes. Our results are somewhat ambiguous, suggesting that integrating genetic association study results with functional genomic and pharmacologic studies is necessary to shed light on genetically mediated targets for longevity-enhancing drugs. Such integration will require more sophisticated data sets, phenotypic definitions, and bioinformatics approaches to be useful. Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are naturally occurring genetic variants in such a target that affect longevity as well as the molecular function of that target (eg, the variants influence the expression of the target, acting as "expression quantitative trait loci" or "eQTLs"), this could support a causal relationship between the pharmacologic modulation of the target and longevity and thereby validate the target at some level. We considered the gene targets of many pharmacologic interventions hypothesized to enhance human longevity and explored how many variants there are in those targets that affect gene function (eg, as expression quantitative trait loci). We also determined whether variants in genes associated with longevity-related phenotypes affect gene function or are in linkage disequilibrium with variants that do, and whether pharmacologic studies point to compounds exhibiting activity against those genes. Our results are somewhat ambiguous, suggesting that integrating genetic association study results with functional genomic and pharmacologic studies is necessary to shed light on genetically mediated targets for longevity-enhancing drugs. Such integration will require more sophisticated data sets, phenotypic definitions, and bioinformatics approaches to be useful.Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are naturally occurring genetic variants in such a target that affect longevity as well as the molecular function of that target (eg, the variants influence the expression of the target, acting as "expression quantitative trait loci" or "eQTLs"), this could support a causal relationship between the pharmacologic modulation of the target and longevity and thereby validate the target at some level. We considered the gene targets of many pharmacologic interventions hypothesized to enhance human longevity and explored how many variants there are in those targets that affect gene function (eg, as expression quantitative trait loci). We also determined whether variants in genes associated with longevity-related phenotypes affect gene function or are in linkage disequilibrium with variants that do, and whether pharmacologic studies point to compounds exhibiting activity against those genes. Our results are somewhat ambiguous, suggesting that integrating genetic association study results with functional genomic and pharmacologic studies is necessary to shed light on genetically mediated targets for longevity-enhancing drugs. Such integration will require more sophisticated data sets, phenotypic definitions, and bioinformatics approaches to be useful. |
| Author | Miller, Richard A Goetz, Laura H Schork, Nicholas J McCorrison, Jamison Girke, Thomas |
| Author_xml | – sequence: 1 givenname: Jamison surname: McCorrison fullname: McCorrison, Jamison organization: Graduate Program in Bioinformatics and Systems Biology, University of California-San Diego, Phoenix, Arizona – sequence: 2 givenname: Thomas surname: Girke fullname: Girke, Thomas organization: Institute for Integrative Genome Biology, University of California, Riverside, Phoenix, Arizona – sequence: 3 givenname: Laura H surname: Goetz fullname: Goetz, Laura H organization: Department of Medical Oncology, City of Hope National Medical Center, Duarte, California – sequence: 4 givenname: Richard A surname: Miller fullname: Miller, Richard A organization: Glenn Center for the Biology of Aging, University of Michigan, Ann Arbor – sequence: 5 givenname: Nicholas J surname: Schork fullname: Schork, Nicholas J organization: Department of Family Medicine and Public Health, University of California-San Diego |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31724058$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUEtLxDAYDLLiPvToVXL0sHXzaJusN9mXwoKCK3grafu1RtpkTVJh_fVWXMG5zByGYWbGaGCsAYQuKbmhZM5nNThr1KxuvhhJT9CIikRGCU9eB__0EI29fyc_SNgZGnIqWEwSOUKwAQNBF_i52--tC7iyDm-tqeFTh0O0Mm_KFNrUeOm6Gu-UqyH4W_zgfQd-ip8cNLrVRrkDXqqgpliZEq-70DnAS-2gCNoaf45OK9V4uDjyBL2sV7vFfbR93Dws7rZRwUUaopzHLCU0rmjOJMw5UJlCyitKgUGeK5BMCsFIMSeFlFKVqZBK8DSOc9kPK9kEXf_m7p396AuGrNW-gKZRBmznM8ZpnAjCpeytV0drl7dQZnun235F9ncN-wbvzWhp |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
| Copyright_xml | – notice: The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/gerona/glz206 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Social Welfare & Social Work |
| EISSN | 1758-535X |
| ExternalDocumentID | 31724058 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: NIH HHS grantid: S10 OD016290 – fundername: NIA NIH HHS grantid: U01 AG022303 – fundername: NIA NIH HHS grantid: UH2 AG064706 |
| GroupedDBID | --- -ET .2P .I3 .ZR 0R~ 18M 1TH 29L 2FS 4.4 48X 5GY 5RE 5VS 5WD 6PF 70D 85S AABZA AACZT AAIMJ AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAVLN AAWTL ABDFA ABEJV ABEUO ABGNP ABIXL ABKDP ABMNT ABNHQ ABNKS ABPBX ABPPZ ABPQP ABPTD ABQLI ABVGC ABWJO ABWST ABXVV ABXZS ABZBJ ACGOD ACKOT ACNCT ACPRK ACUFI ACUTJ ACUTO ADBBV ADEYI ADGKP ADGZP ADHKW ADHZD ADIPN ADMHG ADNBA ADOCK ADQBN ADRTK ADVEK ADYKR ADYVW AEGPL AEJOX AEKSI AELWJ AEMDU AEMQT AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXAL AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ARIXL ATGXG BAYMD BCRHZ BEYMZ BKOMP BQDIO BSWAC BTRTY BVRKM BZKTN C45 CDBKE CGR CQJDY CUY CVF CWPEY CZ4 DAKXR DILTD D~K EBS ECM EE~ EIF EMOBN ENERS F5P F9B FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HF~ HW0 HZ~ IOX J21 KAQDR KOO KOP KSI KSN L7B M-Z M49 MHKGH ML0 N9A NGC NLBLG NOMLY NOYVH NPM NU- O9- OAUYM OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OPAEJ OVD OWPYF PAFKI PEELM PQQKQ Q1. Q5Y RD5 RGE ROX ROZ RUSNO RW1 RXO RXW SJN TAE TEORI TJX TLC UPT WH7 X7H XZL YAYTL YCJ YKOAZ YKV YQT YXANX YZZ ~91 7X8 ABUFD AJBYB |
| ID | FETCH-LOGICAL-c376t-b3426014f1b28e93e186e63f11e2ebbae8287720c90c888ad678a73644b8052d2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000501738300011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1758-535X |
| IngestDate | Sun Nov 09 11:12:44 EST 2025 Thu Apr 03 07:08:03 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl_1 |
| Keywords | Human Aging Mortality Longevity |
| Language | English |
| License | The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c376t-b3426014f1b28e93e186e63f11e2ebbae8287720c90c888ad678a73644b8052d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7330475 |
| PMID | 31724058 |
| PQID | 2314570388 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2314570388 pubmed_primary_31724058 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-11-13 |
| PublicationDateYYYYMMDD | 2019-11-13 |
| PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-13 day: 13 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The journals of gerontology. Series A, Biological sciences and medical sciences |
| PublicationTitleAlternate | J Gerontol A Biol Sci Med Sci |
| PublicationYear | 2019 |
| SSID | ssj0000052 |
| Score | 2.3160107 |
| SecondaryResourceType | review_article |
| Snippet | Interventions meant to promote longevity and healthy aging have often been designed or observed to modulate very specific gene or protein targets. If there are... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | S61 |
| SubjectTerms | Forecasting Humans Longevity - drug effects Longevity - genetics Preliminary Data Quantitative Trait Loci |
| Title | Genetic Support for Longevity-Enhancing Drug Targets: Issues, Preliminary Data, and Future Directions |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31724058 https://www.proquest.com/docview/2314570388 |
| Volume | 74 |
| WOSCitedRecordID | wos000501738300011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3JS8NAFMYHtSJeXOpWN0YQTw3NZLJMvIjYFg-29FAxtzKTvESxJDVpBf3rfZOk6EUQvOQQGAiTN29-b5bvI-Qy8rjjcRVi8AosUMBUOKSwSsExaYZuHCrly9JswhsORRD4o3rBraiPVS5zYpmooyzUa-Qd5BBbq0UJcTN7M7RrlN5drS00VkmDI8roqPYC8QN_S8cdnCGF4XAnqDU2sYjvJJAj6XaS6adlur_TZTnL9Lf_-307ZKvmS3pbBcQuWYG0STYG9Q56k5xW93HpE0xjmQO9ossXWf66R0DLUGNTqt0-kcwpMi19yNIEtMeE0UuftT5HmtBuvkjouDxGXlzTysOvTUc5TEubsPyDduVctqlMI9ovdUtonV0xzPfJY783vrs3aicGI8QENDcU10L2zI6ZsgT4HJhwweUxY2CBUhK0bL5nmaFvhlhSywinQOlxZC2lLRMi64CspVkKR4QqKV0A4MKTwo6YLx2bASDlMVeoyI1b5GLZvxOMdL19IVPIFsXku4db5LD6SZNZJckxQQpCNHHE8R9an5BNpB5fXyhk_JQ0YhzncEbWw_f5S5GflyGEz-Fo8AWzGdF- |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+Support+for+Longevity-Enhancing+Drug+Targets%3A+Issues%2C+Preliminary+Data%2C+and+Future+Directions&rft.jtitle=The+journals+of+gerontology.+Series+A%2C+Biological+sciences+and+medical+sciences&rft.au=McCorrison%2C+Jamison&rft.au=Girke%2C+Thomas&rft.au=Goetz%2C+Laura+H&rft.au=Miller%2C+Richard+A&rft.date=2019-11-13&rft.issn=1758-535X&rft.eissn=1758-535X&rft.volume=74&rft.issue=Suppl_1&rft.spage=S61&rft_id=info:doi/10.1093%2Fgerona%2Fglz206&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-535X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-535X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-535X&client=summon |